The current standard of care in the treatment of prostate cancer is to use chemotherapy (Taxotere) only in late stage hormone refractory prostate cancer. Most other cancers use chemotherapy agents at a much earlier stage then used for prostate cancer. Prostate cancer cells divide at a rate that is not much faster than normal cell [...]
I'm not sure if Dev is turning five or 25 next week. The kid really thinks he's grown. He's also kind of funny and cute. I think I'll keep him. Here are three things that fly off the top of my head that he's said over the last three weeks. I'm not sure why they [...]
According to the American Cancer Society 28,000 men will die in 2008 from prostate cancer. Prostate Cancer incidence rates are comparable to Breast Cancer rates. Yet, federal funding is significantly higher for Breast Cancer research than for Prostate Cancer. In 2008, there will be virtually the same number of new cases of Prostate Cancer (186,320) [...]
April 14 in the Journal of Clinical Oncology reported that Eric M. Horwitz, M.D., from Fox Chase Cancer Center in Philadelphia, and colleagues treated 1,554 prostate cancer patients with goserelin and flutamide (ADT) before and during radiation therapy. The men were then randomly assigned to receive no further ADT or 24 additional months of ADT. [...]
The other day an institution that shall remain nameless contacted me via form letter to notify me that my social security number was "accidentally" published on their public website along with thousands of others. They basically said "our bad" and suggested that I do something to make sure that I don't become the victim of [...]